A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection

PHASE1

Phase

UNKNOWN

Status

Enrollment

INDUSTRY

Sponsor class

Conditions

BIOLOGICAL: COVIDITY (SCOV1 and SCOV2) administered via needle-free intradermal injection
BIOLOGICAL: COVIDITY (SCOV1 and SCOV2) administered via needle-free intramuscular injection
BIOLOGICAL: COVIDITY (SCOV2 only) administered via needle-free intradermal injection to vaccine naive and/or previously vaccinated participants
BIOLOGICAL: COVIDITY (SCOV2 only) administered via needle-free intramuscular injection to vaccine naive and/or previously vaccinated participants
BIOLOGICAL: COVIDITY (SCOV2 only) administered via needle-free intradermal injection to previously infected participants
BIOLOGICAL: COVIDITY (SCOV2 only) administered via needle-free intramuscular injection to previously infected participants

Scancell Ltd